GE HealthCare has signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA) to develop next-generation advanced point-of-care ultrasound technology with new artificial intelligence (AI) applications, to help healthcare professionals of all skill levels quickly diagnose and provide timely treatment for patients with lung disease and traumatic injuries to the abdomen, chest and head.
GE HealthCare will develop new technologes to accelerate trauma triage and treatment, potentially changing the standard of care.
Building on its existing point-of-care ultrasound technology portfolio, GE HealthCare will develop an advanced probe and ultrasound system, along with novel AI technology, to facilitate the acquisition and interpretation of ultrasound exams for users of all skill levels.
The proposed devices will cover indications for multiple injury types: blunt and penetrating trauma, head trauma, lung injury (including blast lung), as well as multiple lung pathologies encountered outside of trauma care, such as those seen in infectious diseases.
GE HealthCare will develop technology and AI applications to be compatible with select point-of-care ultrasound systems from its product portfolio to facilitate rapid assessment of patients across a wide range of environments and care settings.
To view the source version, please click HERE.